Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ITIH5 and ECRG4 DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder Cancer

7 Feb 2020

Abstract excerpt

Bladder cancer is one of the more common malignancies in humans and the most expensive tumor for treating in the Unites States (US) and Europe due to the need for lifelong surveillance. Non-invasive tests approved by the FDA have not been widely adopted in routine diagnosis so far. Therefore, we aimed to characterize the two putative tumor suppressor genes ECRG4 and ITIH5 as novel urinary DNA methylation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32046186
DOI: 10.3390/ijms21031117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ITIH5 and ECRG4 DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder CancerPMID 32046186Read ↗

Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validationSemantic proximity Read ↗

Non-Invasive Urine-Based Diagnostic Technologies for Early Bladder CancerSemantic proximity Read ↗

Evaluation of Sensitive Urine DNA-Based PENK Methylation Test for Detecting Bladder Cancer in Patients with HematuriaSemantic proximity Read ↗

Bladder cancer detection in urine by novel methylation markersSemantic proximity Read ↗

BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patientsSemantic proximity Read ↗

Three Epigenetic Biomarkers, <i>GDF15</i> , <i>TMEFF2</i> , and <i>VIM</i> , Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine SamplesSemantic proximity Read ↗

Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder CancerSemantic proximity Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillanceSemantic proximity Read ↗

Urine cell-based DNA methylation classifier for monitoring bladder cancerSemantic proximity Read ↗

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients.Semantic proximity Read ↗

UroMark—a urinary biomarker assay for the detection of bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.